Psychedelics Investing: The Ultimate Due Diligence Guide

What are the red flags to notice in psychedelic investments?

As with any due diligence project, investors who become familiar with a sector can start to notice red flags when examining companies more closely before deploying any capital.

The challenge in psychedelics is that it’s a new market where established, tried-and-true business metrics don’t always apply.

Matt Carr, chief trends strategist at the Oxford Club, shared with INN some of the ways he likes to break down psychedelics investments and determine which stocks could be winners.

Where to start with so many new companies?

There are a lot of interesting and dynamic options when it comes to psychedelics stocks. Companies across the board are vying for the attention of investors who are curious to participate firsthand.

INN asked experts what people who are diving into space should know before making picks, and the key lesson was that this is a young sector barely out of the starting point.

“I wouldn’t even say that we’re in the earliest innings of a game, because I don’t even think we’re actually on the field quite yet,” Carr said.

Carr, alongside Marik Hazan, founder and CEO of Energia, broke down the current landscape for psychedelics companies and those investing in them.